BioCentury
ARTICLE | Company News

Multimeric Biotherapeutics, Topotarget deal

November 7, 2011 8:00 AM UTC

Topotarget granted Multimeric exclusive rights to Topotarget's multimeric fusion proteins containing tumor necrosis factor (TNF) superfamily ligands (TNFSFs) for all therapeutic uses. The deal includ...